BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/15/2025 9:46:09 AM | Browse: 12 | Download: 37
 |
Received |
|
2025-09-26 03:35 |
|
Peer-Review Started |
|
2025-09-26 08:41 |
|
First Decision by Editorial Office Director |
|
2025-10-21 06:29 |
|
Return for Revision |
|
2025-10-21 06:29 |
|
Revised |
|
2025-10-30 13:33 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-12 02:49 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-12 07:44 |
|
Articles in Press |
|
2025-11-12 07:44 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-03 00:27 |
|
Publish the Manuscript Online |
|
2025-12-15 09:46 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Zhejiang University index predicts metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Man Zhang, Miao-Guang Yu, Xiang-Nan Shen and Guo-Bin Kang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guo-Bin Kang, Academic Fellow, Department of Cardiology 1, Hebei Provincial Hospital of Chinese Medicine/The First Affiliated Hospital of Hebei University of Chinese Medicine, The First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang, 050000, China. Electronic address: kanggb1229@126.com, Shijiazhuang 050000, Hebei, China. kanggb1229@126.com |
| Key Words |
Zhejiang University index; Metabolic dysfunction-associated steatotic liver disease; Type 2 diabetes mellitus; Predictive biomarker; Cross-sectional study; Pharmacotherapy confounding |
| Core Tip |
This correspondence critically evaluates the study by Tao et al on the ability of the Zhejiang University index to predict metabolic dysfunction-associated steatotic liver disease (MASLD) in type 2 diabetes mellitus patients. It commends the index as it is a minimally invasive biomarker panel and methodologically sound but highlights several limitations, such as the reliance on a hospitalized patient sample, lack of information on pharmacological treatments, the inherent constraints of ultrasound imaging, and the cross-sectional nature of the study. The authors suggest that future research should aim at prospective validation in outpatient settings and exploring the underlying mechanisms of MASLD. |
| Publish Date |
2025-12-15 09:46 |
| Citation |
Zhang M, Yu MG, Shen XN, Kang GB. Zhejiang University index predicts metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus patients. World J Diabetes 2025; 16(12): 114565 |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i12/114565.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i12.114565 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
